Ser-Ap-Es (Hydralazine Hydrochloride / Hydrochlorothiazide / Reserpine) - Indications and Dosage

INDICATIONS AND USAGE

Hypertension (see boxed WARNING).

DOSAGE AND ADMINISTRATION

Dosage should be determined by individual titration (see boxed WARNING). Dosage regimens that exceed 0.25 mg of reserpine per day are not recommended.

HOW SUPPLIED

Tablets – round, salmon pink, dry-coated (imprinted CIBA 71) 0.1 mg of reserpine, 25 mg of hydralazine hydrochloride, 15 mg of hydrochlorothiazide

Bottles of 100.......................................... NDC 0083-0071-30

Bottles of 1000.........................................NDC 0083-0071-40

Do not store above 30ºC (86ºF). Dispense in tight, light-resistant container (USP).

C97-38 (Rev. 1/98)

Novartis Pharmaceuticals Corporation

East Hanover, New Jersey 07936